Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats

被引:6
|
作者
Yamamoto, Y [1 ]
Yasuda, Y
Komiya, Y
机构
[1] Otsuka Pharmaceut Co Ltd, Inst New Drug Res 1, Tokushima 7710192, Japan
[2] Gunma Univ, Sch Med, Dept Mol & Cellular Neurobiol, Gunma 3718511, Japan
[3] Otsuka Pharmaceut Co Ltd, Pharmaceut Mkt Div, Tokushima 7710192, Japan
关键词
streptozotocin-diabetic; rat; cilostazol; antiplatelet vasodilating agent; phosphodiesterase inhibitor;
D O I
10.1016/S0014-2999(00)00804-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the effects of cilostazol, an antiplatelet and vasodilating agent, on axonal transport patterns of cytoskeletal proteins in the motor fibers of sciatic nerve of streptozotocin-induced diabetic rats. Proteins labeled with L-[S-35]methionine in 6-mm consecutive segments of the nerve were analyzed electrophoretically following fractionation into Triton-soluble and-insoluble subpopulations. Transport rates of proteins (particularly neurofilaments) in slow component a were reduced by 50% 2 weeks after labeling (4 weeks after streptozotocin). An apparent reduction of tubulin and actin was observed at later intervals after induction of diabetes. Actin transported in slow component b was also impaired, though to a lesser extent than in component a. Cilostazol prevented transport impairment of both slow components a and b without affecting hyperglycemia or reduction in body weight gain. These results suggest that in sciatic motor fibers early defects in slowly transported proteins are more marked in slow component a, and that impairment may be caused primarily by hemodynamic abnormalities. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [41] NEUROPROTECTIVE EFFECTS OF HYDROXYTYROSOL IN STREPTOZOTOCIN-DIABETIC RATS
    Pozo Marquez, M.
    Romero, L.
    Reyes de la Vega, J. J.
    Lopez-Villodres, J. A.
    Munoz-Marin, J.
    Guerrero, A.
    Guzman Moscoso, R.
    De la Cruz Cortes, J. P.
    Gonzalez-Correa, J. A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 28 - 28
  • [42] TISSUE DISTRIBUTION OF CARNITINE IN STREPTOZOTOCIN-DIABETIC RATS
    BAHL, JJ
    BROOKS, S
    BRESSLER, R
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 617 - 617
  • [43] Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats
    DallAgo, P
    Fernandes, TG
    Machado, UF
    Bello, AA
    Irigoyen, MC
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1997, 30 (01) : 119 - 124
  • [44] RENAL-FUNCTION IN STREPTOZOTOCIN-DIABETIC RATS
    JENSEN, PK
    CHRISTIANSEN, JS
    STEVEN, K
    PARVING, HH
    DIABETOLOGIA, 1981, 21 (04) : 409 - 414
  • [45] EFFECTS OF SULFONYLUREA DRUGS ON STREPTOZOTOCIN-DIABETIC RATS
    MAEKAWA, H
    SEKIYA, A
    YAMAMOTO, J
    KATO, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1978, 28 : P167 - P167
  • [46] THE EFFECTS OF INDOMETHACIN ON HYPERCALCIURIA IN STREPTOZOTOCIN-DIABETIC RATS
    BUCK, AC
    LOTE, , CJ
    HEAD, S
    FAULKNER, K
    UROLOGICAL RESEARCH, 1988, 16 (03): : 208 - 208
  • [47] CYCLOSPORINE-A NEPHROTOXICITY IN STREPTOZOTOCIN-DIABETIC RATS
    WHITING, PH
    THOMSON, KJ
    SAUNDERS, NJ
    SIMPSON, JG
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 946 - 947
  • [48] Urinary fibronectin excretion in streptozotocin-diabetic rats
    Jonas, E
    JackleMeyer, I
    Szukics, B
    Stolte, H
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1996, 34 (06): : 485 - 492
  • [49] Cilostazol Ameliorates Motor Dysfunction and Schwann Cell Impairment in Streptozotocin-Induced Diabetic Rats
    Chang, Lin-Li
    Wu, Yu-Ming
    Wang, Hung-Chen
    Tseng, Kuang-Yi
    Wang, Yi-Hsuan
    Lu, Yen-Mou
    Cheng, Kuang-, I
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [50] ASCORBIC-ACID SUPPLEMENTATION PREVENTS HYPERLIPIDEMIA AND IMPROVES MYOCARDIAL PERFORMANCE IN STREPTOZOTOCIN-DIABETIC RATS
    DAL, S
    MCNEILL, JH
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 27 (01) : 11 - 18